版权说明 操作指南
首页 > 成果 > 详情

Artemisinin antagonizes cognitive disorder in hyperuricemia through glutamate receptor-interacting protein 1-suppressed pyroptosis

认领
导出
Link by DOI
反馈
分享
QQ微信 微博
成果类型:
期刊论文
作者:
Chen, Yanfang;Chen, Shuangxi;Wang, Huiqing;Cao, Peng
通讯作者:
Cao, P
作者机构:
[Chen, Shuangxi; Chen, Yanfang] Univ South China, Affiliated Hosp 1, Hengyang Med Sch, Dept Neurol, Hengyang, Peoples R China.
[Wang, Huiqing; Cao, Peng] Univ South China, Affiliated Hosp 1, Hengyang Med Sch, Dept Hepatopancreatobiliary Surg, 69 Chuanshan Rd, Hengyang 421001, Hunan, Peoples R China.
通讯机构:
[Cao, P ] U
Univ South China, Affiliated Hosp 1, Hengyang Med Sch, Dept Hepatopancreatobiliary Surg, 69 Chuanshan Rd, Hengyang 421001, Hunan, Peoples R China.
语种:
英文
关键词:
artemisinin;cognitive disorder;glutamate receptor-interacting protein 1;GSDMD-N;hyperuricemia;pyroptosis
期刊:
NEUROREPORT
ISSN:
0959-4965
年:
2025
卷:
36
期:
3
页码:
145-152
基金类别:
Hunan Provincial Natural Science Foundation of China [2023JJ60362, 2023JJ60363]; Guiding project of Hengyang science and Technology Bureau [202222035719]
机构署名:
本校为第一且通讯机构
摘要:
The prevalence of hyperuricemia (HUA) is climbing worldwide and persistent elevation of serum uric acid impairs cognitive function. This study aimed to explore the mechanisms of Artemisinin (Art) antagonizing cognitive disorder in HUA by suppressing pyroptosis. A mouse model of HUA was established by intraperitoneal injection of 300 mg/kg potassium oxonate (PO) in C57BL/6 mice for 14 days. The mice were simultaneously treated with Art, an agonist of pyroptosis Polyphyllin VI (PPVI), or glutamate receptor-interacting protein 1 (GRIP1) knockdown...

反馈

验证码:
看不清楚,换一个
确定
取消

成果认领

标题:
用户 作者 通讯作者
请选择
请选择
确定
取消

提示

该栏目需要登录且有访问权限才可以访问

如果您有访问权限,请直接 登录访问

如果您没有访问权限,请联系管理员申请开通

管理员联系邮箱:yun@hnwdkj.com